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A problem-led application : ageing populations 
To understand what is needed for problem-led future-oriented tech-mining, we have 
chosen the grand societal challenge of “healthcare for the ageing population”.  
Across the world, the percentage of people over 60 years of age is increasing 
(partially related to lower fertility rates and longer life expectancy).  This will mean a 
fundamental demographic change towards a larger proportion of the population 
being over 60 years of age, potentially leading to the need to work for longer (see 
the recent debate and changes in retirement age) and certainly for the those over 
60 to play an active role in society for a longer period of time (WHO 2012).  This poses 
a large challenge for the global healthcare system, particularly on ailments, 
disorders and diseases which dominate in the aged, and reduce the potential for 
“active ageing”. With this challenge in mind, we have chosen the challenge of 
mitigating the effects of (or combat) the diseases which are prevalent in the aged, 
which will become more pronounced over the coming years as the aged 
population increases, with its economic and social consequences. 
Restricting our trial case with a specific technology: nano-enabled drug 
delivery options 
To restrict our study to a manageable size we will explore a promising field of R&D 
labeled “nano-enabled drug delivery” as the test case, from a number of promising 
technologies for improving health and well-being of the aged.   Nanotechnologies 
offer promising approaches to deliver therapies for a number of diseases prevalent 
in the aged such as arthritis, diabetes, dementia, and a number of cancers.  Building 
on the results of a research project and expert engagement exercise on nano-
enabled drug delivery and a study of the main diseases where delivery of drugs is an 
issue, our aim is to explore how nanotechnologies are being employed to deliver 
drugs for diseases prevalent in ageing population.    
However, high uncertainty and the dynamics of nanotechnologies pose real 
challenges for capturing the broad scope of technology development.  Thus, we 
triangulate multiple databases with differing degrees of heterogeneity such as Web 
of Science (fundamental research), EI Compendex (engineering R&D), Derwent 
World Patent Index, and Factiva (business-related information) by conducting 
research profiling to characterize entire bodies of different object-oriented 
literatures. 
  
The FIP Process 
We have devised a 5-stage approach for Forecasting Innovation Pathways (“FIP”) 
(Figure 1).  This targets integrating a) demand articulation and characterisation with 
b) heavily empirical “Tech Mining” with c) highly qualitative expert-based multi-
stakeholder interactions (culminating in rich Innovation Pathway Maps). This paper 
explores systematization of the FIP analytical approach in two ways: 
1) Hybrid data approaches tap structured text database searches together 
with unstructured website crawls.  The latter tap into ‘gray literatures,’ recent 
developments, and diverse perspectives.   
2) Applying artificial intelligence tools to the Tech Mining.  Once one has a set 
of multi-database NEST search results, we are working to devise algorithms to 
help extract key technology components and actors, and potential 
applications.  We illustrate using temporal change patterns, leading actor 
indicators, and thesauri of identified terms.   
 
The paper presents our progress on Stages 0, 1 and 2 for nano-enabled drug delivery 
options for disease prevalent in the ageing population.   We put-forward that our first 
data—first steps in the broader FIP framework—provides useful findings in of 
themselves.   By presenting these first findings in this exploratory project we hope to 
stimulate discussion on both our framework and our findings, and learn from other’s 
experiences in applying tech-mining in problem-led (or demand driven) projects.  
 
Figure 1: FIP framework with addition of Stage 0 (to clarify demand)  
